ProfileGDS4718 / 228050_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 71% 49% 64% 46% 53% 79% 84% 60% 52% 62% 63% 51% 76% 76% 77% 71% 63% 64% 79% 35% 55% 63% 60% 63% 64% 76% 61% 68% 57% 79% 75% 77% 38% 59% 84% 82% 60% 57% 56% 67% 57% 76% 66% 70% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.9643671
GSM549102patient 115, normal, homogenized [OPG study]5.4518549
GSM549104patient 119, normal, homogenized [OPG study]6.4725164
GSM549108patient 138, normal, homogenized [OPG study]5.341146
GSM549119patient 077, normal, homogenized [OPG study]5.7125853
GSM549133patient 032, cancer, homogenized [OPG study]7.938579
GSM549139patient 042, cancer, homogenized [OPG study]8.3689984
GSM549099patient 107, normal, homogenized [OPG study]6.1403460
GSM549109patient 139, normal, homogenized [OPG study]5.6740352
GSM549110patient 046, normal, homogenized [OPG study]6.2374362
GSM549114patient 063, normal, homogenized [OPG study]6.3185263
GSM549122patient 082, normal, homogenized [OPG study]5.5783851
GSM549134patient 033, cancer, homogenized [OPG study]7.4537476
GSM549136patient 036, cancer, homogenized [OPG study]7.4932176
GSM549140patient 044, cancer, homogenized [OPG study]7.5766377
GSM549111patient 047, normal, homogenized [OPG study]6.953171
GSM549113patient 057, normal, homogenized [OPG study]6.3120363
GSM549132patient 031, cancer, homogenized [OPG study]6.4226564
GSM549137patient 038, cancer, homogenized [OPG study]7.8105479
GSM549142patient 047, cancer, homogenized [OPG study]4.8657135
GSM549100patient 110, normal, homogenized [OPG study]5.7831155
GSM549107patient 135, normal, homogenized [OPG study]6.2798363
GSM549115patient 068, normal, homogenized [OPG study]6.129460
GSM549116patient 072, normal, homogenized [OPG study]6.3751963
GSM549120patient 078, normal, homogenized [OPG study]6.3965364
GSM549131patient 030, cancer, homogenized [OPG study]7.5668376
GSM549118patient 074, normal, homogenized [OPG study]6.1683561
GSM549129patient 027, cancer, homogenized [OPG study]6.7923568
GSM549123patient 088, normal, homogenized [OPG study]5.9035257
GSM549124patient 006, cancer, homogenized [OPG study]7.6219979
GSM549126patient 015, cancer, homogenized [OPG study]7.3443575
GSM549128patient 025, cancer, homogenized [OPG study]7.5793477
GSM549103patient 117, normal, homogenized [OPG study]4.9761938
GSM549117patient 073, normal, homogenized [OPG study]5.9891559
GSM549138patient 041, cancer, homogenized [OPG study]8.3462184
GSM549141patient 045, cancer, homogenized [OPG study]8.1903282
GSM549130patient 028, cancer, homogenized [OPG study]6.1024260
GSM549101patient 111, normal, homogenized [OPG study]5.9878657
GSM549105patient 128, normal, homogenized [OPG study]5.9003356
GSM549106patient 134, normal, homogenized [OPG study]6.682867
GSM549112patient 048, normal, homogenized [OPG study]5.9169657
GSM549125patient 011, cancer, homogenized [OPG study]7.3540676
GSM549127patient 024, cancer, homogenized [OPG study]6.6638366
GSM549135patient 035, cancer, homogenized [OPG study]6.9281970